Article Text

Download PDFPDF
Reply to Letter to the Editor regarding “Ophthalmic artery angioplasty for age-related macular degeneration”
  1. Ivan Lylyk1,
  2. Carlos Bleise1,
  3. Pedro N Lylyk1,
  4. Nicolas Perez2,
  5. Javier Lundquist1,
  6. Esteban Scrivano1,
  7. Anibal A Francone2,
  8. Martin Charles2,
  9. Tamara Zompa2,
  10. Pedro Lylyk1
  1. 1Interventional Neuroradiology and Neurosurgery, Instituto Médico ENERI, Clínica La Sagrada Familia, Buenos Aires, Argentina
  2. 2Ophthalmology, Centro Oftalmológico Dr Daniel Charles S.A, Buenos Aires, Argentina
  1. Correspondence to Dr Ivan Lylyk, Department of Interventional Neuroradiology and Neurosurgery, Instituto Médico ENERI, Clínica La Sagrada Familia, Buenos Aires, Argentina; ivan{at}lylyk.com.ar

Statistics from Altmetric.com

We are delighted that the authors of the letter1 see merit in what we have done, and the previous imaging studies in age-related macular degeneration (AMD) that they cite served as inspiration for our intervention. We agree wholeheartedly with the need for better imaging, especially swept-source optical coherence tomography (SS-OCT) imaging of the choroid both before and after the ophthalmic artery (OA) intervention.2 Our …

View Full Text

Footnotes

  • Twitter @eneri_neuro

  • Contributors All authors contributed equally.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests PNL: consultant for OcuDyne, Phenox, Medtronic; institutional grant or contract from Philips. TZ: consultant for OcuDyne. MC: consultant for OcuDyne.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles